Notification
No new Notification messages
Zinka Logistics Solutions IPO is Open!
Apply for the Zinka Logistics Solutions IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
max healthcare ins ltd stock

MAX HEALTHCARE INS LTD Share Price

1010.6 4.34 (0.43%)
Nov 18 2024 12:07 PM Healthcare NSE: MAXHEALTH

MAX HEALTHCARE INS LTD Share Price Update

As of the latest trading session, MAX HEALTHCARE INS LTD share price is currently at 1010.6, which is up by 4.34 from its previous closing. Today, the stock has fluctuated between 987.05 and 1058.85. Over the past year, MAX HEALTHCARE INS LTD has achieved a return of 67.94 %. In the last month alone, the return has been 6.22 %. Read More...

MAX HEALTHCARE INS LTD Performance

Day Range

Low987.05 High1058.85
1004.15

52 Week Range

Low 590.10 High 1118.00
1004.15

MAX HEALTHCARE INS LTD Share Price

22377

543220

MAXHEALTH

img img img img
No Data Available

Open Price

1055.10

Prev. Close

1006.25

Volume (Shares)

1341113.00

Total traded value

13466.78

Upper Circuit

1207.50

Lower Circuit

805.00

Note: The current prices & values are delayed, Login to your account for live updates.

MAX HEALTHCARE INS LTD Fundamentals


(Standalone)

Market Cap (Cr) 98221.46
PE Ratio (TTM) 124.51
Book Value / Share 81.72
Beta 0.47
ROE 9.34%
EPS (TTM) 8.08
Dividend Yield 0.15%
Net Profit Qtr (Cr) 231.30

MAX HEALTHCARE INS LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 686.11
Operating Expense 501.47
Net Profit 231.30
Net Profit Margin (%) 33.71
Earnings Per Share (EPS) 2.00
EBITDA 358.18
Effective Tax Rate (%) 27.29
Particulars JUN 2024 (Values in Cr)
Revenue 621.39
Operating Expense 461.09
Net Profit 154.14
Net Profit Margin (%) 24.80
Earnings Per Share (EPS) 1.59
EBITDA 240.94
Effective Tax Rate (%) 24.12
Particulars MAR 2024 (Values in Cr)
Revenue 610.11
Operating Expense 457.26
Net Profit 241.77
Net Profit Margin (%) 39.62
Earnings Per Share (EPS) 2.49
EBITDA 337.20
Effective Tax Rate (%) 16.80
Particulars DEC 2023 (Values in Cr)
Revenue 590.75
Operating Expense 430.10
Net Profit 158.12
Net Profit Margin (%) 26.76
Earnings Per Share (EPS) 1.63
EBITDA 242.83
Effective Tax Rate (%) 22.23
Particulars SEP 2023 (Values in Cr)
Revenue 596.87
Operating Expense 434.88
Net Profit 161.31
Net Profit Margin (%) 27.02
Earnings Per Share (EPS) 1.66
EBITDA 250.87
Effective Tax Rate (%) 23.19
Particulars MAR 2024 (Values in Cr)
Revenue 2341.36
Operating Expense 1747.62
Net Profit 687.26
Net Profit Margin (%) 29.35
Earnings Per Share (EPS) 7.07
EBITDA 1033.26
Effective Tax Rate (%) 20.54
Particulars MAR 2023 (Values in Cr)
Revenue 1904.66
Operating Expense 1485.69
Net Profit 694.31
Net Profit Margin (%) 36.45
Earnings Per Share (EPS) 7.16
EBITDA 728.26
Effective Tax Rate (%) -23.29
Particulars MAR 2022 (Values in Cr)
Revenue 1775.36
Operating Expense 1502.99
Net Profit 331.52
Net Profit Margin (%) 18.67
Earnings Per Share (EPS) 3.43
EBITDA 571.38
Effective Tax Rate (%) 17.22
Particulars MAR 2021 (Values in Cr)
Revenue 1030.78
Operating Expense 1073.08
Net Profit -164.45
Net Profit Margin (%) -15.95
Earnings Per Share (EPS) -1.91
EBITDA 56.73
Effective Tax Rate (%) -12.28
Particulars MAR 2020 (Values in Cr)
Revenue 59.26
Operating Expense 128.57
Net Profit -2.96
Net Profit Margin (%) -4.99
Earnings Per Share (EPS) -0.05
EBITDA 60.24
Effective Tax Rate (%) 4.51
Particulars MAR 2024 (Values in Cr)
Book Value / Share 86.51
ROE % 13.37
ROCE % 14.96
Total Debt to Total Equity 0.13
EBITDA Margin 29.28
Particulars MAR 2023 (Values in Cr)
Book Value / Share 76.31
ROE % 16.12
ROCE % 13.85
Total Debt to Total Equity 0.12
EBITDA Margin 28.56
Particulars MAR 2022 (Values in Cr)
Book Value / Share 64.79
ROE % 10.15
ROCE % 11.09
Total Debt to Total Equity 0.17
EBITDA Margin 25.45
Particulars MAR 2021 (Values in Cr)
Book Value / Share 58.37
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.40
EBITDA Margin 20.69
Particulars MAR 2020 (Values in Cr)
Book Value / Share 18.38
ROE % 8.03
ROCE % 9.77
Total Debt to Total Equity 1.29
EBITDA Margin 19.18
Particulars MAR 2024 (Values in Cr)
Book Value / Share 79.03
ROE % 9.34
ROCE % 11.64
Total Debt to Total Equity 0.07
EBITDA Margin 42.24
Particulars MAR 2023 (Values in Cr)
Book Value / Share 72.53
ROE % 10.40
ROCE % 8.49
Total Debt to Total Equity 0.08
EBITDA Margin 36.46
Particulars MAR 2022 (Values in Cr)
Book Value / Share 65.09
ROE % 5.41
ROCE % 6.89
Total Debt to Total Equity 0.08
EBITDA Margin 30.80
Particulars MAR 2021 (Values in Cr)
Book Value / Share 61.49
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.13
EBITDA Margin 24.75
Particulars MAR 2020 (Values in Cr)
Book Value / Share 53.52
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.25
EBITDA Margin 101.65
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1099.27
Total Assets 11999.94
Total Liabilities 11999.94
Total Equity 8408.14
Share Outstanding 971912408
Price to Book Ratio 10.38
Return on Assets (%) 8.81
Return on Capital (%) 11.07
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1468.07
Total Assets 10101.85
Total Liabilities 10101.85
Total Equity 7409.59
Share Outstanding 970922825
Price to Book Ratio 6.08
Return on Assets (%) 10.92
Return on Capital (%) 13.84
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 499.31
Total Assets 9189.13
Total Liabilities 9189.13
Total Equity 6282.47
Share Outstanding 969613455
Price to Book Ratio 5.33
Return on Assets (%) 6.58
Return on Capital (%) 8.63
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 652.92
Total Assets 8544.44
Total Liabilities 8544.44
Total Equity 5638.68
Share Outstanding 965945006
Price to Book Ratio 3.35
Return on Assets (%) -1.60
Return on Capital (%) -2.1
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 280.79
Total Assets 3824.38
Total Liabilities 3824.38
Total Equity 987.41
Share Outstanding 537244328
Price to Book Ratio 0.00
Return on Assets (%) 2.49
Return on Capital (%) 4.18
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 720.04
Total Assets 9068.87
Total Liabilities 9068.87
Total Equity 7680.76
Share Outstanding 971912408
Price to Book Ratio 10.38
Return on Assets (%) 7.57
Return on Capital (%) 8.57
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1231.46
Total Assets 8420.33
Total Liabilities 8420.33
Total Equity 7042.11
Share Outstanding 970922825
Price to Book Ratio 6.08
Return on Assets (%) 8.24
Return on Capital (%) 9.26
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 386.51
Total Assets 7811.76
Total Liabilities 7811.76
Total Equity 6311.38
Share Outstanding 969613455
Price to Book Ratio 5.33
Return on Assets (%) 4.24
Return on Capital (%) 4.93
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 610.99
Total Assets 7142.95
Total Liabilities 7142.95
Total Equity 5939.43
Share Outstanding 965945006
Price to Book Ratio 3.35
Return on Assets (%) -2.30
Return on Capital (%) -2.62
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 269.10
Total Assets 2511.06
Total Liabilities 2511.06
Total Equity 1246.04
Share Outstanding 537244328
Price to Book Ratio 0.00
Return on Assets (%) 1.11
Return on Capital (%) 1.36
Particulars MAR 2024 (Values in Cr)
Net Income 1365.32
Cash from Operations 1391.08
Cash from Investing -1285.45
Cash from Financing -263.74
Net change in Cash -427.39
Free Cash Flow 2177.02
Particulars MAR 2023 (Values in Cr)
Net Income 1063.72
Cash from Operations 1445.25
Cash from Investing -102.32
Cash from Financing -288.56
Net change in Cash 893.25
Free Cash Flow 1780.86
Particulars MAR 2022 (Values in Cr)
Net Income 738.90
Cash from Operations 849.58
Cash from Investing -763.80
Cash from Financing -294.17
Net change in Cash -317.45
Free Cash Flow 1402.92
Particulars MAR 2021 (Values in Cr)
Net Income -68.65
Cash from Operations 59.84
Cash from Investing -73.00
Cash from Financing 191.33
Net change in Cash 236.19
Free Cash Flow 178.26
Particulars MAR 2020 (Values in Cr)
Net Income 89.08
Cash from Operations 262.53
Cash from Investing -126.68
Cash from Financing 144.05
Net change in Cash 267.19
Free Cash Flow 351.27
Particulars MAR 2024 (Values in Cr)
Net Income 864.96
Cash from Operations 761.78
Cash from Investing -805.64
Cash from Financing -245.91
Net change in Cash -438.46
Free Cash Flow 1223.13
Particulars MAR 2023 (Values in Cr)
Net Income 563.14
Cash from Operations 784.72
Cash from Investing 301.69
Cash from Financing -54.47
Net change in Cash 943.69
Free Cash Flow 905.22
Particulars MAR 2022 (Values in Cr)
Net Income 400.49
Cash from Operations 490.19
Cash from Investing -669.65
Cash from Financing -161.48
Net change in Cash -383.77
Free Cash Flow 861.18
Particulars MAR 2021 (Values in Cr)
Net Income -146.46
Cash from Operations 201.33
Cash from Investing -365.61
Cash from Financing 412.41
Net change in Cash 271.27
Free Cash Flow 232.74
Particulars MAR 2020 (Values in Cr)
Net Income 27.88
Cash from Operations 123.87
Cash from Investing -192.61
Cash from Financing 329.36
Net change in Cash 264.86
Free Cash Flow 168.08
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6857.65 83.35 13.15 98602.49 5205.20 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 52.46 0.00 3.29 98.32 44.00 / 107.94
SHREE PACETRONIX LTD. 118.40 19.07 3.17 42.62 114.95 / 316.85
TRANSGENE BIOTEK LTD. 6.81 0.00 4.76 51.60 5.79 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6857.65 87.81 12.03 98602.49 5205.20 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 39.10 0.00 -20.94 29.21 26.83 / 54.65
KOVAI MEDICAL CENTER & HOSPITA 5073.90 27.52 5.70 5550.85 3050.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1025.40
  • 26 Days 1001.00
  • 10 Days 1029.60
  • 50 Days 973.40
  • 12 Days 1026.40
  • 100 Days 948.10
  • 20 Days 1005.40
  • 200 Days 758.80
1010.37
PIVOT
First Resistance 1027.83
Second Resistance 1053.77
Third Resistance 1071.23
First Support 984.43
Second Support 966.97
Third Support 941.03
RSI 63.07
MACD 25.41
Commodity Channel Index (CCI) 18.80
ADX 26.67
Williams % R -60.07

Over 1 Month

down

6.22

Over 3 Months

down

15.66

Over 6 Months

down

23.48

Over 1 Year

down

67.94

Over 3 Years

down

40.39

Over 5 Years

down

55.19

MAX HEALTHCARE INS LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

MAX HEALTHCARE INS LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
7.4
Promoter Holdings
23.73
FII
57.29
DII
11.55
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Abhay Soi Shareholding of Promoter and Promoter Group 2.30717699E8 23.73
Government Of Singapore Public Shareholding 6.5274269E7 6.71
New World Fund Inc Public Shareholding 5.9793818E7 6.15
Smallcap World Fund, Inc Public Shareholding 4.3037352E7 4.43
Hdfc Mutual Fund Public Shareholding 2.3722608E7 2.44
Sbi Mutual Fund Public Shareholding 2.2845175E7 2.35
Canara Robeco Mutual Fund Public Shareholding 1.5692242E7 1.61
Monetary Authority Of Singapore Public Shareholding 1.4858729E7 1.53
Government Pension Fund Global Public Shareholding 1.1454286E7 1.18
Fidelity Investment Trust : Fidelity Emerging Markets Fund Public Shareholding 1.06853E7 1.1
Vanguard Total International Stock Index Fund Public Shareholding 1.0311212E7 1.06
Kotak Funds - India Midcap Fund Public Shareholding 1.023115E7 1.05
Aditya Soi Shareholding of Promoter and Promoter Group 60000.0 0.01
Kayak Investments Holding Pte. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0

MAX HEALTHCARE INS LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-08 1.0 Final 2023-09-08 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About MAX HEALTHCARE INS LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by MAX HEALTHCARE INS LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Max Healthcare Institute Ltd?

Answer Field

The share price of Max Healthcare Institute Ltd for NSE is ₹ 1010.6 and for BSE is ₹ 1010.35.

What is the Market Cap of Max Healthcare Institute Ltd?

Answer Field

The market cap of Max Healthcare Institute Ltd for NSE is ₹ 9,82,21.46 Cr. and for BSE is ₹ 9,81,97.16 Cr. as of now.

What is the 52 Week High and Low of Max Healthcare Institute Ltd?

Answer Field

The 52 Week High and Low of Max Healthcare Institute Ltd for NSE is ₹ 1118.00 and ₹ 590.10 and for BSE is ₹ 1117.05 and ₹ 590.25.

How to Buy Max Healthcare Institute Ltd share?

Answer Field

You can trade in Max Healthcare Institute Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Max Healthcare Institute Ltd?

Answer Field

The 1 year returns on the stock has been 67.94%.

What is the Current Share Price of Max Healthcare Institute Ltd?

Answer Field

Max Healthcare Institute Ltd share price is for NSE ₹ 1010.6 & for BSE ₹ 1010.35 as on Nov 18 2024 12:07 PM.

What is the Market Cap of Max Healthcare Institute Ltd Share?

Answer Field

The market cap of Max Healthcare Institute Ltd for NSE ₹ 9,82,21.46 & for BSE ₹ 9,81,97.16 as on Nov 18 2024 12:07 PM.

What is the P/E Ratio of Max Healthcare Institute Ltd Share?

Answer Field

As on Nov 18 2024 12:07 PM the price-to-earnings (PE) ratio for Max Healthcare Institute Ltd share is 124.51.

What is the PB ratio of Max Healthcare Institute Ltd Share?

Answer Field

As on Nov 18 2024 12:07 PM, the price-to-book (PB) ratio for Max Healthcare Institute Ltd share is 81.72.

How to Buy Max Healthcare Institute Ltd Share?

Answer Field

You can trade in Max Healthcare Institute Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Max Healthcare Institute Ltd Share on Bajaj Broking App?

Answer Field

To buy Max Healthcare Institute Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Max Healthcare Institute Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader